World ADC San Diego

We are exhibiting at World ADC San Diego from 7th – 8th September 2022 on booth 5. Use the form below to request a meeting with a member of our team.

Request a Meeting

This field is for validation purposes and should be left unchanged.

Join our lunch session

Join us for our talk, “How to progress from lead candidate nomination to clinic: An ADC process and analytical development to manufacturing case study”, on 8th September at 1pm where our experts will demonstrate:

  • Phase appropriate development and validation
  • Product quality consistency through research, toxicology and GMP manufactured batches
  • Standardisation of robust, flexible and scalable manufacturing unit operations

Meet our speakers:

Stewart Mitchell

Stewart is EVP and Site Head at the Deeside facility, and is responsible for leading Sterling’s bioconjugation and ADC services. His main focus is to grow capacity and capabilities within this area of the business, as well as integrate Sterling’s High Potency API offering within its ADC services.

Stephanie Johnson

Stephanie is Senior Development Scientist at Sterling’s Deeside facility, where she has worked for more than ten years; having made thousands of ADCs. Stephanie is responsible for a team who supports discovery, process and analytical development.


Paulius Milasauskas

Paulius is a Senior Analytical Scientist at the Deeside facility and is responsible for the analytical and formulation development of ADCs. His main responsibility is to grow the analytical offering at the bioconjugation site.


Related Events


We will be exhibiting at ChemOutsourcing 2022, at booth 67, from 8th - 9th September 2022.

CPhI Worldwide

We are exhibiting at CPhI Worldwide from 1st - 3rd November 2022.

[Infographic] Optimising ADCs through three critical components


Antibody drug conjugates (ADC): The magic bullets


The use of mass spectrometry to aid ADC development


ADC overview